Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-16-073485
Filing Date
2016-07-27
Accepted
2016-07-27 13:01:26
Documents
1
Period of Report
2016-07-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3625
  Complete submission text file 0001140361-16-073485.txt   5163
Mailing Address 1311 PINEVIEW DRIVE SUITE 501 MORGANTOWN WV 26505
Business Address 1311 PINEVIEW DRIVE SUITE 501 MORGANTOWN WV 26505 304 292-2226
Protea Biosciences Group, Inc. (Issuer) CIK: 0001335103 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 955 HARTMAN RUN ROAD MORGANTOWN WV 26507
Business Address
TURNER STEPHEN C (Reporting) CIK: 0001529510 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51474 | Film No.: 161786198